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Abstract
Background
Somatic migration of Toxocara canis- and T. cati-larvae in humans may cause neurotoxo-
carosis (NT) when larvae accumulate and persist in the central nervous system (CNS).
Host- or parasite-induced immunoregulatory processes contribute to the pathogenesis;
however, detailed data on involvement of bioactive lipid mediators, e.g. oxylipins or eico-/
docosanoids, which are involved in the complex molecular signalling network during infec-
tion and inflammation, are lacking.
Methodology/Principal findings
To elucidate if T. canis- and T. cati-induced NT affects the homeostasis of oxylipins during
the course of infection, a comprehensive lipidomic profiling in brains (cerebra and cerebella)
of experimentally infected C57BL/6J mice was conducted at six different time points post
infection (pi) by liquid-chromatography coupled to electrospray tandem mass spectrometry
(LC-ESI-MS/MS). Only minor changes were detected regarding pro-inflammatory prosta-
glandins (cyclooxygenase pathway). In contrast, a significant increase of metabolites result-
ing from lipoxygenase pathways was observed for both infection groups and brain regions,
implicating a predominantly anti-inflammatory driven immune response. This observation
was supported by a significantly increased 13-hydroxyoctadecadienoic acid (HODE)/9-
HODE ratio during the subacute phase of infection, indicating an anti-inflammatory
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Conclusions/Significance
The obtained results demonstrate the influence of Toxocara spp. on oxylipins as part of the
immune response of the paratenic hosts. Furthermore, this study shows differences in the
alteration of the oxylipin composition between T. canis- and T. cati-brain infection. Results
contribute to a further understanding of the largely unknown pathogenesis and mechanisms
of host-parasite interactions during NT.
Author summary
Neurotoxocarosis (NT) is induced by larvae of the zoonotic roundworms Toxocara canis
and T. cati migrating and persisting in the central nervous system of paratenic hosts, and
may be accompanied by severe neurological symptoms. Toxocara spp. are known to mod-
ulate the hosts’ immune response, but data concerning involvement of signalling mole-
cules are lacking. An important class of mediators participating in the complex molecular
signalling network during infection and inflammation are bioactive regulatory lipids,
derived from arachidonic acid and other polyunsaturated fatty acids. For a better under-
standing of inflammatory processes in the brain during an infection with Toxocara spp., a
comprehensive analysis of regulatory lipids was conducted. The infection was predomi-
nantly characterised by only minor changes in the pattern of pro-inflammatory oxylipins,
while anti-inflammatory metabolites, derived from lipoxygenase pathways, were signifi-
cantly elevated in the subacute phase as well as in the beginning of the chronic phase of
infection. This trend was also reflected in the 13-HODE/9-HODE ratio, a biomarker for
the immunological status of an active infection. Obtained data provide a valuable insight
in the host’s immune reaction as response against neuroinvasive Toxocara spp.-larvae,
contributing to the characterisation of the mostly unknown pathogenesis of NT.
Introduction
Toxocara canis (Werner, 1782) and T. cati (Schrank, 1788) are globally distributed, intestinal
helminth parasites with canids and felids as definitive hosts [1]. Humans and a wide range of
other species can act as paratenic hosts after accidental ingestion of infective stages (L3) of Tox-
ocara spp., resulting in persistence of the larvae in the body tissues [2, 3]. The infection of para-
tenic hosts comprises different stages, starting with larvae entering the cardiovascular system
and reaching the liver and lungs during the first week post infection. This acute stage of toxo-
carosis is called the hepato-pulmonary phase. The myotropic-neurotropic phase indicates the
beginning of the chronic stage and is characterised by migration and accumulation of larvae
throughout somatic tissues [3].
Humans may get infected due to inadequate hygiene, geophagia or via foodborne transmis-
sion [4]. Even though toxocarosis is one of the most frequent helminthoses in humans, the
global importance of this zoonosis is probably underestimated [2, 5].
Cerebral oxylipin alterations during neurotoxocarosis
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007706 September 26, 2019 2 / 20
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
Human toxocarosis may result in a variety of clinical symptoms. Depending on the somatic
distribution of the larvae and the occurring symptoms, toxocarosis is currently classified into
four syndromes: covert toxocarosis, visceral larva migrans (VLM), ocular larva migrans
(OLM) and neurotoxocarosis (NT), whereby NT results from accumulation and persistence of
Toxocara spp.-larvae in the CNS [2]. Neurotoxocarosis may lead to encephalitis, myelitis, cere-
bral vasculitis or optic neuritis [6, 7] and affected patients may suffer from headache, fever,
oversensitivity to light, weakness, confusion, tiredness and visual impairment [6–9]. While the
localization of Toxocara-larvae in the human brain has not been systematically investigated, it
has been demonstrated that larvae exhibit a species-specific tropism in the murine brain.
T. canis-larvae are mainly located in the cerebrum, while T. cati-larvae prefer the cerebellum
but mainly accumulate in muscle tissue [10]. Consequently, T. canis- and T. cati-induced NT
differs in the severity of structural brain damage as well as the severity of neurological symp-
toms and behavioural alterations [10–12]. However, host- or parasite-induced immunoregula-
tory processes contributing to pathogenesis as well as molecular pathogenic mechanisms are
only marginally identified yet.
Bioactive regulatory lipids (also called oxylipins), such as octadecanoids, eicosanoids and
docosanoids, constitute an important class of molecules involved in the complex molecular
signalling network during infection and inflammation. Regulatory lipids comprise a plethora
of structurally and stereochemically different bioactive mediators derived from arachidonic
acid (ARA) and related ω-6-polyunsaturated fatty acids (PUFAs) like dihomo-γ-linolenic acid
(DGLA) and linoleic acid (LA) as well as ω-3-PUFAs such as α-linolenic acid (ALA), eicosa-
pentaenoic acid (EPA) and docosahexaenoic acid (DHA). Regulatory lipids are generated
from the oxidation of different PUFAs by three major enzymatic pathways (an overview of
these and selected regulatory lipids is given in Fig 1): The cyclooxygenase pathway (COX-1
and COX-2) results in different prostanoids like prostaglandins, prostacyclins and thrombox-
anes. Leukotrienes as well as several hydroxy fatty acids are derived from the lipoxygenase
pathway (5-LOX, 12-LOX and 15-LOX). The murine 15-LOX (alox15) additionally acts as a
12-lipoxygenating enzyme, converting PUFAs to metabolites similar to those derived from
12-LOX [13]. Thus, hereinafter these metabolites are referred as 12/15-LOX-metabolites. The
superfamily of cytochrome P450 (CYP 450) monooxygenase enzymes catalyses the epoxida-
tion of ARA to epoxyeicosatrienoic acids (EpETrEs), which are hydrolysed to corresponding
dihydroxy-derivatives (DiHETrEs) by soluble epoxide hydrolases (sEH). In addition, CYP 450
enzymes catalyse the ω-hydroxylation of PUFAs, forming terminal (ω and ω-n) hydroxylated
fatty acids [14, 15]. Different regulatory lipids have been detected in cerebral tissues, playing
important roles in a variety of physiological processes, such as the maintenance of homeostasis
and neural functions including spatial learning and synaptic plasticity [16–19]. Under disease
conditions, several oxylipins like COX-derived prostanoids and 5-LOX-derived leukotrienes
are involved in inflammatory processes including fever, sensitivity to pain, oxidative stress,
and neurodegeneration [20]. In contrast, several metabolites formed via the 12/15-LOX
pathway, have been described to exhibit anti-inflammatory activities, e.g. by co-activating per-
oxisomal proliferator activating-receptors (PPAR), regulating cytokine generation and modu-
lating expression of inflammation related genes [21, 22]. Furthermore, the 12/15-LOX-derived
13-HODE is an agonist for PPAR-γ and exhibit anti-inflammatory properties [23, 24]. In con-
trast, 9-HODE is mainly generated by non-enzymatic reactions and activates the G protein-
coupled receptor G2A, which mediates intracellular calcium mobilization and JNK activation,
promoting inflammatory processes [25, 26]. Both metabolites derive from linoleic acid and
have been suggested as markers for lipid peroxidation in various chronic diseases [27]. There-
fore, Tam et al. [28] proposed the ratio of 13-HODE to 9-HODE as useful biomarker to indi-
cate the immunological status of an active infection. The involvement of regulatory lipids in
Cerebral oxylipin alterations during neurotoxocarosis
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inflammatory processes has been examined in numerous studies. Most of these studies focused
primarily on selected oxylipins, and only a few studies have comprehensively examined quan-
titative changes during the course of bacterial [29, 30] and viral [28] infections. While these
studies were conducted with tibiotarsal tissues [29], blood and exudates [30], and nasopharyn-
geal lavages [28] as sample material, nothing is known about the dynamic lipidomic profile in
the brain during cerebral infections. Furthermore, information about a comprehensive
description of these processes during parasitic infections is lacking. Therefore, this study
aimed to characterise for the first time alterations in the brain pattern of bioactive regulatory
lipids during acute, subacute and chronic NT in T. canis- and T. cati-infected mice as a model
for paratenic hosts [3].
Material and methods
Ethics statement
Animal experiments were performed in accordance with the German Animal Welfare act in
addition to national and international guidelines for animal welfare. Experiments were permit-
ted by the ethics commission of the Institutional Animal Care and Use Committee (IACUC)
of the German Lower Saxony State Office for Consumer Protection and Food Safety (Nieder-
saechsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit) under reference
numbers 33.9-42502-05-01A038 (experimental infection of dogs and cats), 33.12-42502-04-
14/1520, 33.12-42502-04-15/1869 and 33.14-42502-04-12/0790 (experimental infection of
mice).
Fig 1. Simplified overview of the generalised major biosynthetic cascades and selected lipid mediators derived
from linoleic acid (LA), arachidonic acid (ARA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).
Cyclooxygenases (COX) convert polyunsaturated fatty acids (PUFAs) to prostanoids. Leukotrienes (LTs) derive from
the 5-lipoxygenase pathway (5-LOX), while further lipoxygenases (8-LOX and 12/15-LOX) convert PUFAs to
corresponding hydroxylated fatty acids (HODE, HETE, HEPE and HDHA). 8,15- and 5,15-dihydroxyeicosatetraenoic
acid (8,15- and 5,15-DiHETE) as well as specialised pro-resolving mediators (SPMs) like resolvins (Rv), neuroprotectin
D1 (NPD1) and lipoxins (Lx) require at least two consecutive enzymatic conversions. Various cytochrome P450
monooxygenase enzymes (CYP 450) catalyse the epoxidation of PUFAs, illustrated by ARA-derived epoxyeicosatrienoic
acids (EpETrEs).
https://doi.org/10.1371/journal.pntd.0007706.g001
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Biological material and infection of mice as a model for human
neurotoxocarosis
Eggs of field isolates of Toxocara canis (field isolate HannoverTcanis2008) and T. cati (field
isolate HannoverTcati2010), maintained at the Institute for Parasitology, University of Veteri-
nary Medicine Hannover, were obtained from faeces of experimentally infected dogs and cats,
respectively, by a combined sedimentation/flotation technique. Eggs were cultured in tap
water for about 4 weeks in a controlled temperature chamber at 25±1 ˚C with oxygenation two
times per week to allow development of third-stage larvae. Infective eggs were subsequently
stored in tap water at 4 ˚C until use.
For the oxylipin analysis, 4-week-old female C57BL/6JRccHsd mice were purchased from
Harlan Laboratories (The Netherlands) and were allowed to acclimatize for 14 days before the
start of the experiment, while for microarray analysis, 5-week-old female C57BL/6JRccHsd
were purchased and an acclimatisation time of one week was provided. Mice were housed in
Makrolon cages in a 12/12 hours dark/light cycle receiving standard rodent diet (Altromin
1324, Germany) and water ad libitum. With regard to unsaturated fatty acids, the standard
rodent diet contained 2,210 mg/kg α-linolenic acid and 16,152 mg/kg linoleic acid. At the age
of 6 weeks, 45 animals each were infected orally with 2000 embryonated T. canis or T. cati
eggs, respectively, administered at once in a volume of 0.5 ml tap water, whereas 45 control
mice received the same volume of the vehicle (tap water) only. At each time point of investiga-
tion in the acute phase (day 7 post infectionem [pi]), the subacute phase (days 14 and 28 pi)
and the chronic phase (days 42, 70 and 98 pi), five mice were sacrificed by cervical dislocation
for the oxylipin analysis. Additionally, as of day 14 pi, three mice of each study group were
euthanized for microarray analyses at each time point. For the oxylipin analyses, brains were
removed, subdivided into cerebrum and cerebellum, and immediately snap frozen in liquid
nitrogen. During further processing, specimens were homogenised in liquid nitrogen using a
mortar and pestle, and 50±5 mg of homogenised tissue were weighed and stored individually
at -150 ˚C until oxylipin extraction. For the microarray analysis, brains were removed and sub-
divided into left and right hemispheres as well as cerebrum and cerebellum. Right cerebrum
and cerebellum hemispheres were stored individually in RNAlater RNA stabilization reagent
(Qiagen, Hilden, Germany) at 4 ˚C overnight and afterwards at -80 ˚C until RNA isolation
[31].
Oxylipin extraction
Extraction and analysis of oxylipins in brain tissue was carried out as described with modifica-
tions [32, 33]. Samples were thawed on ice and 300 μl acidified methanol (0.2% formic acid
[Fisher Scientific, Germany] in LC-MS grade MeOH [Fisher Scientific, Germany]), 10 μl anti-
oxidant solution (0.2 mg/mL EDTA [Sigma Aldrich; Germany], 0.2 mg/mL butylated
hydroxytoluene [Sigma Aldrich; Germany], 100 μM indomethacin [Sigma Aldrich; Germany],
100 μM TUPS [34]) in MeOH/H2O (50/50, v/v) [35]) as well as 10 μl of internal standards
(each 100 nM 2H4-6-keto-PGF1α,
2H4-PGE2,
2H4-PGD2,
2H4-TxB2,
2H4- LTB4,
2H4-9-HODE,
2H8-5-HETE,
2H8-12-HETE,
2H6-20-HETE,
2H11-14,15-DiHETrE,
2H11-14(15)-EpETrE,
2H4-
9(10)-EpOME, 2H4-9(10)-DiHOME,
2H4-15-F2t-IsoP,
2H11-5(R,S)-5-F2t-IsoP, Cayman Chem-
icals (local distributor: Biomol, Germany) [32] were added. Subsequently, the samples were
homogenised again using two 3 mm metal beads in a ball mill (Retsch, Germany) for 8 min at
15 Hz, followed by centrifugation at 20,000 x g for 10 min at 4 ˚C. The supernatant was diluted
with 2700 μl of 1 M sodium acetate (pH 6.0; Carl Roth, Germany). Solid phase extraction was
carried out on cartridges with an unpolar (C8)/anion exchange mixed mode material (Bond
Elut Certify II, 200 mg; Agilent, Germany), preconditioned with one column volume of
Cerebral oxylipin alterations during neurotoxocarosis
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MeOH and one column volume of 0.1 M sodium acetate with 5% MeOH (pH 6.0). After sam-
ple loading, the cartridge was washed with one column volume of water and one column vol-
ume of MeOH/H2O (50/50, v/v). Cartridges were dried for 20 min by low vacuum (*200
mbar). Oxylipins were eluted with n-hexane/ethyl acetate (25/75, v/v) (n-hexane: HPLC grade
[Carl Roth Germany]; ethyl acetate [Sigma Aldrich; Germany]) with 1% acetic acid (Sigma
Aldrich; Germany) in glass tubes containing 6 μl of 30% glycerol (Sigma Aldrich; Germany) in
MeOH. The eluate was evaporated in a vacuum centrifuge (1 mbar, 30 ˚C, 40–60 min; Christ,
Germany) until only the glycerol plug was left. Dried residues were immediately frozen at
-80 ˚C for at least 30 min and reconstituted in 50 μl of MeOH containing a second internal
standard allowing the evaluation of extraction efficacy afterwards. Samples were centrifuged
(20,000 x g, 10 min, 4 ˚C). Oxylipins were quantified by liquid chromatography-mass spec-
trometry (LC–MS/MS) following negative electrospray ionization in scheduled SRM mode on
a QTRAP6500 mass spectrometer (Sciex, Germany) injecting 5 μl as described by Rund et al.
[32]. Authentic standard substances of oxylipins were purchased from Cayman Chemicals
(local distributor: Biomol, Hamburg, Germany). As the standard for NPD1 is not commer-
cially available it was synthesized as follows: The NPD1-methyl ester was synthesized as
described for its C10-epimer [36] replacing the (S)-1,2,4-butanetriol by its (R)-enantiomer as
starting material for the introduction of the E,E-iododiene. Methyl ester-NPD1 was than
hydrolyzed with 1 M LiOH in MeOH/H2O (50/50, v/v) followed by acidification with McIl-
vains buffer (pH 5) producing NPD1 as a colorless oil in 97% yield. Peak integration and deter-
mination of oxylipin concentration was conducted using Multiquant (Sciex, Germany).
RNA isolation from brains and microarray analysis of genes involved in the
oxylipin-synthesis
RNA isolation and whole genome microarray analysis was conducted as described by Janecek
et al. [31]. Briefly, the total RNA content from three cerebra and cerebella from each group at
time points 14, 28, 42, 70 and 90 pi was isolated using the RNeasy Lipid Tissue Mini kit (Qia-
gen, Germany). After further processing, quality control and Cy3-labelling of isolated RNA,
labelled cRNA was hybridised to Agilent’s 4x44k Mouse V2 (Design ID:026655) for 17 h at
65 ˚C and scanned as described by Pommerenke et al. [37]. Obtained data for ptgs1 (COX-1;
Probe A_51_P279100), ptgs2 (COX-2; Probe A_51_P254855), aloxe3 (A_55_P2023523), alox5
(A_51_P247249), alox5ap (A_51_P235687), alox8 (A_55_P2029957), alox12 (A_51_P520306),
alox12b (A_55_P2121682), alox12e (A_51_P471659) and alox15 (A_51_P252565) were statis-
tically analysed as described below.
Data analysis
Normality of distribution of all sample sets was analysed by the Kolmogorov-Smirnov test. For
normally distributed variables the One-way ANOVA or for skewed distributions the Kruskal-
Wallis test was used to reveal statistically significant differences between the infection and con-
trol group at each time point. To account for multiple comparisons, false discovery rate adjust-
ment of P-values was carried out in R (version 3.1.2; [38]) and a Q-value of 0.1 was considered
as statistically significant. For Q-values below 0.1, the following post-hoc tests were carried
out: unpaired t-test for normally distributed datasets or Mann-Whitney U test (MWU) for
skewed distributions, whereby P�0.05 was considered as statistically significant. If a metabo-
lite could not be detected in one of the study groups, the lower limit of quantification was used
for statistics. Statistical analyses were conducted with GraphPad Prism™ software (version 6.03;
GraphPad Software, California, USA). Due to normally distributed datasets for the ratio of
13-HODE to 9-HODE as well as the transcription rates of oxylipin-related genes, an unpaired
Cerebral oxylipin alterations during neurotoxocarosis
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t-test was used to reveal statistical differences between infected and uninfected groups (Graph-
Pad Prism™ software [version 6.03; GraphPad Software, California, USA]).
Ratios of lipid mediators and transcriptional levels of mentioned genes between the unin-
fected control and infection groups over the course of infection were calculated by dividing
each individual value of the T. canis-, T. cati- and uninfected control group by the mean value
of the uninfected control group at the respective point in time. If a metabolite was not detected
in the corresponding uninfected control group, the lower limit of quantification was used to
calculate the fold change in infected mice. The fold changes were log2 transformed and the
means of the log2 transformed fold-changes were presented as heatmaps to identify relative
changes. Heat maps were visualised with MeV [39] (Version 4.9.0, TM4 Software suit [http://
mev.tm4.org]).
Results
Clinical assessment, body and brain weights
Clinical assessment of mice as well as data on body weight, whole brain weight, cerebrum and
cerebellum weight as well as brain to body mass ratio have been published previously by Wain-
dok and Strube [40], using the same mice to investigate changes in brain cytokine and chemo-
kine patterns during neurotoxocarosis. In short, infected mice showed varying degrees of
neurobehavioural alterations as described by Janecek et al. [12], with T. canis-infected mice
developing symptoms like ataxia to paresis and paraplegia or incoordination earlier and more
severe than T. cati-infected mice. The brain/body mass ratio in comparison to the uninfected
control group was significantly lower at day 14 pi in T. canis- and T. cati-infected mice
(P = 0.0038 and P = 0.0024, respectively) and at day 28 pi in T. canis-infected mice (P =
0.0353). Similarly, the cerebrum/body mass-ratio was significantly lower at day 14 pi in
T. canis- and T. cati-infected mice (P = 0.0005 and P = 0.0003, respectively) and at day 28 pi in
T. canis-infected mice (P = 0.0396), but increased significantly at day 70 pi in the latter group
(P = 0.0079). Regarding the cerebellum/body mass-ratio, statistically significant differences
were not detectable between the infected and uninfected groups.
Composition of bioactive lipid metabolites by metabolic pathways
A total of 73 different oxylipins were successfully detected and quantified in brains of Toxocara
spp.-infected mice and uninfected controls. To assess the composition of bioactive lipid
metabolites over the course of infection, analysed metabolites of different PUFAs were sum-
marised by their major formation routes, i.e. COX, LOXs, and CYP 450 as well as non-enzy-
matic autoxidation. The proportion of the respective pathways contributing to the analysed
oxylipins in the brains of Toxocara spp.-infected and uninfected mice is illustrated in Fig 2.
Concentrations and P-values regarding the comparison to uninfected control mice are pro-
vided in S1 Table. Absolute levels of COX-derived metabolites in the cerebra and cerebella did
not differ significantly between infected and uninfected control mice with the exception of
T. cati-infected cerebella at day 42 pi. Infection with T. canis and T. cati led to similar alter-
ations of CYP 450-derived metabolites in the cerebra, namely a significant increase at days 14,
42 and 70 pi. In the cerebella, CYP 450-derived metabolites were significantly increased at
days 14 and 42 pi in both infection groups. The total amount of 5-LOX-derived oxylipins was
significantly higher in the cerebra of T. canis-infected mice at days 28 and 42 pi and of T. cati-
infected mice at day 42 pi. In the cerebella, 5-LOX-metabolites were significantly increased at
day 7 pi for T. canis- and at day 14 pi for T. cati-infected mice, as well as in both infection
groups at day 42 pi. Metabolites derived by 8-LOX were significantly elevated in the cerebra of
both infection groups at days 14, 28 and 42 pi. Regarding the cerebella, a significant increase
Cerebral oxylipin alterations during neurotoxocarosis
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was observed at days 14, 28 and 98 pi in T. canis-infected mice and at days 28 and 42 pi in T.
cati-infected mice. In addition, levels of 12/15-LOX-derived oxylipins were significantly ele-
vated at days 14, 28 and 42 pi in the cerebra of both infection groups. Significantly increased
levels of 12/15-LOX metabolites were also observed in the cerebella of both infection groups at
days 14 and 42 pi. The levels of non-enzymatically derived oxylipins did not differ significantly
between the uninfected control group and the two infection groups in both brain parts.
Alterations in individual oxylipins
While Fig 2 illustrates relative patterns of detected lipid mediators based on their major meta-
bolic formation pathways during infection, Fig 3 displays alterations of individual bioactive
lipid mediators and their fold change in infected compared to uninfected control mice. Oxyli-
pin concentrations and P-values regarding the comparison to the control mice are given in
S2 Table (cerebrum) and S3 Table (cerebellum). Metabolites are classified by their major
Fig 2. Stacked bar graphs represent the percentage-ratio of all detected metabolites summed by their assumed major formation route in the a) cerebra and b)
cerebella of Toxocara spp.-infected and uninfected mice. Each column represents data from a single sample (n = 5).
https://doi.org/10.1371/journal.pntd.0007706.g002
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Fig 3. Heatmap representing the mean fold-change of each lipid mediator in uninfected controls as well as in T. canis- and T.
cati-infected mice. For clarity, classification of metabolites is generalised based on their major biosynthetic pathways. Metabolites
below the quantification limit are displayed in grey.
https://doi.org/10.1371/journal.pntd.0007706.g003
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biosynthetic pathways, however metabolite formation through other enzymes or non-enzy-
matic peroxidation cannot be excluded.
COX-derived metabolites. In the cerebra of T. canis-, but not T. cati-infected mice, a sta-
tistically significant decrease of different prostaglandins as well as 13-HDHA was observed at
day 7 pi. A significant increase of various prostaglandin concentrations in T. canis-infected
cerebra was detected in the subacute phase of infection at day 28 pi (cf. S2 Table). Levels of
PGE2, PGJ2, 15-deoxy-PGJ2 and PGD1 were also elevated in cerebra of T. cati-infected mice at
day 28 pi. Furthermore, EPA-derived PGD3 and TxB3 were only detected in T. canis-infected
cerebra. In T. canis-infected cerebella, no significant alterations in COX-derived metabolites
were detected over the course of infection, while cerebella of T. cati-infected mice showed a
statistically significant increase of different prostaglandins at day 14 pi (cf. S3 Table).
LOX-derived metabolites. Several LOX-derived metabolites (5-HEPE, 6-trans-LTB4,
7-HDHA, 15-HEPE) were only detected in T. canis- as well as T. cati-infected mice, but not in
the control group (Fig 3).
A differential regulation of metabolites generated by 5-LOX was observed for T. canis- as
well as T. cati-induced NT. In the cerebra, levels of LTB4 and 6-trans-LTB4 were significantly
elevated at days 14, 28, 42 and 98 pi, in both infection groups. For 6-trans LTB4, this significant
increase was also detected in the cerebella, where it was observed from day 28 pi until day 70
pi in T. canis-infected mice and at days 14, 42 and 70 pi in T. cati-infected mice. In contrast,
LTB4 was significantly decreased in the cerebella of T. canis-infected mice at day 14 pi, while it
was unaffected in those of T. cati-infected mice.
Furthermore, infection with T. canis as well as T. cati resulted in a significant increase of
8-LOX-derived 8-HETE in the cerebra at days 14, 28, 42 and 98 pi. At these time points, levels
of 8-HETE were also significantly elevated in the cerebella, with the exception of day 98 pi in
T. cati-infected cerebella. Increased levels of 12/15-LOX-derived 12-HETE were detected in
cerebra of both infection groups at days 14 and 42 pi, and additionally at day 28 pi in T. canis-
infected cerebra. In cerebella of both infection groups, significantly elevated concentrations of
12-HETE were detected at days 14 and 42 pi. Furthermore, EPA-derived 12-HEPE was signifi-
cantly elevated at days 14 and 28 pi in both infection groups, and additionally at day 42 pi in T.
cati-infected and day 98 pi in T. canis-infected cerebra, while the cerebellar concentrations of
12-HEPE were increased at day 28 pi in T. canis- and T. cati-infected mice.
Moreover, significantly elevated levels of ARA-derived 15-HETE were detected in the cere-
bra of both infection groups at day 28 pi. In the cerebella, 15-HETE was increased at day 42 pi
in T. canis-, and at days 14 and 42 pi in T. cati-infected mice. DHA-derived 14-HDHA and
17-HDHA were significantly increased at days 14, 28, 42 and 98 pi in the cerebra and at days
14, 28 and 42 pi in the cerebella of both infection groups.
Metabolites derived by multiple enzymatic conversions. The biosynthesis of several
oxylipins requires at least two consecutive conversions by enzymes, e.g. ARA-derived
8,15-DiHETE and 5,15-DiHETE. Both metabolites were detected in the cerebra and cerebella
of infected mice, whereas 8,15-DiHETE was not and 5,15-DiHETE was only sporadically
detected in uninfected control mice. Neuroprotectin D1 (NPD1) was not detected in brains of
uninfected control mice at any time point, but in cerebra and cerebella of infected mice at
most time points during the study period (Fig 4). In cerebra of infected mice, NPD1 concen-
trations were significantly elevated at days 14, 28 and 42 pi in T. canis-infected and at days 14
and 42 pi in T. cati-infected mice. In the cerebellum, significantly elevated levels were mea-
sured additionally at day 98 pi in T. canis-infected and at day 28 pi and in T. cati-infected
mice. Further specialised pro-resolving mediators like RvD1, RvE1 and Lipoxin A4 (LxA4)
were not detected in the present study.
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CYP 450-derived metabolites. Regarding metabolites produced by CYP 450-pathways,
ω-3-PUFA-derived metabolites were mainly detected in infected mice. While EPA-derived
epoxy-fatty acids could not be detected in the sample set, EPA-derived hydroxy- and dihy-
droxy-derivates were mainly detected in the cerebra (e.g. 5,6-DiHETE) or predominantly in
the cerebella (e.g. 20-HEPE) of T. canis-infected mice. These metabolites were only sporadi-
cally detected in T. cati-infected and uninfected control mice. DHA-derived epoxy-fatty acids
were present in the infection groups as well as in the uninfected control group during the
entire study period, whereas corresponding dihydroxy-derivates were mainly detected in cere-
bra and cerebella of infected mice.
Ratio 13-HODE/9-HODE
The ratio of 13-HODE to 9-HODE was shifted towards 13-HODE in the cerebra and cerebella
of T. canis- as well as T. cati-infected mice during the course of infection (Fig 5). A significant
increase of the 13-HODE/9-HODE ratio was already detected in the cerebra of T. canis-
infected mice at days 7 and 14 pi (P = 0.0171 and P = 0.0001), reaching a maximum from days
28 and 42 pi (P�0.0001 and P = 0.0011), while in T. cati-infected cerebra, the ratio peaked
already at day 14 pi and remained significantly increased at days 28 and 42 pi (P = 0.0098,
P = 0.0049 and P = 0.0461, respectively). In both infection groups, the 13-HODE/9-HODE
ratio declined to homeostatic conditions in the later phase of infection at days 70 and 98 pi.
Although the 13-HODE/9-HODE ratio in T. canis- and T. cati-infected cerebella showed a
similar development as in the cerebrum, statistically significant alterations were only detected
at days 7 and 28 pi (P = 0.0006 and P�0.0001) in T. canis- and at days 14 and 28 pi (P = 0.0139
and P = 0.0067) in T. cati-infected mice.
Fig 4. Time course of concentrations of NPD1 (mean ± SEM) in the cerebra and cerebella of uninfected controls as well as T. canis- and T. cati-infected
mice. If the level was below the limit of quantification (LOQ) the LOQ is shown (0.498 fmol/mg). Asterisks indicate statistically significant differences (P�0.05)
between infected and uninfected mice. The square marks an outlier for NPD1 at day 70 pi.
https://doi.org/10.1371/journal.pntd.0007706.g004
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Transcriptomic profiling
Transcriptional alterations of different ptgs (encoding for COX enzymes) and alox (encoding
for LOX enzymes)-genes are shown as fold changes in Fig 6. Transcription of ptgs1 was signifi-
cantly increased in cerebra and cerebella of T. canis-infected mice during the whole study
period (P�0.0418). In T. cati-infected mice, ptgs1-transcription was significantly upregulated
at day 28 pi (P = 0.0406) in the cerebra, and at days 28, 70 and 98 pi (P = 0.0056, P = 0.0453
and P = 0.0418) in the cerebella. By contrast, the transcription rate of ptgs2 was significantly
downregulated in cerebra of T. canis-infected animals at day 28 pi (P = 0.026), cerebra of T.
cati-infected mice were not affected. In the cerebella, a statistically significant increase was
detected at day 98 pi in both infection groups (T. canis: P = 0.0039, T. cati: P = 0.0402). Fur-
thermore, the transcription rate of alox5 and alox5ap (encoding for the 5-LOX activating pro-
tein FLAP) was significantly elevated as of day 14 pi (with the exception of alox5 in the cerebra
at day 14 pi) in both brain parts of T. canis-infected mice (P�0.0348). In brains of T. cati-
infected mice, alox5 was significantly elevated at day 28 pi (P = 0.0266), while no significant
alterations of alox5ap-transcription were detected. The transcription rate of different alox12-
isoforms was mostly unaffected by NT, with a downregulation in both brain areas of T. canis-
infected mice at days 14 (cerebra P = 0.0086; cerebella P = 0.0229) and 42 pi (cerebra P =
0.0061; cerebella P = 0.0398). In T. cati-infected mice, a significant downregulation occurred
at days 14 and 28 pi (P = 0.0336 and P = 0.0229) in the cerebra and day 42 pi (P = 0.0268) in
the cerebella. In contrast, the transcription of alox12e was elevated in the cerebella of T. canis-
infected mice at days 28, 42 and 98 pi (P = 0.0300, P = 0.0021 and P = 0.0300), and at day 42 pi
(P = 0.0017) of T. cati-infected mice. The transcription of alox15 was significantly upregulated
at days 28 pi and 42 pi in cerebra of T. canis (P = 0.0037; P = 0.0037) as well as T. cati-infected
mice (P = 0.0239; P = 0.0464). In the cerebella, T. canis-infection resulted in a significant
upregulation of alox15 at days 14, 28 and 98 pi (P = 0.0191, P = 0.0252 and P = 0.0006),
Fig 5. 13-HODE/9-HODE-ratio (mean ± SEM) in the cerebra and cerebella of uninfected controls as well as T. canis- and T. cati-infected mice. Asterisks
indicate statistically significant differences (P�0.05) between infected and uninfected mice.
https://doi.org/10.1371/journal.pntd.0007706.g005
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while T. cati-infected mice only showed an upregulation on days 28 and 98 pi (P = 0.0068,
P = 0.0251).
Discussion
The central nervous system exhibits inflammatory reactions in response to injury, infection or
disease, comprising the activation of brain microglia, the rapid release of inflammatory media-
tors and invasion of immune cells, among others [41, 42]. Nevertheless, neuroinvasive larvae
of Toxocara spp. are able to accumulate and persist in cerebral tissues [43] and even though
the infection is characterised by neuroinflammatory hallmarks like hemorrhagic lesions, mye-
linophages, spheroids and activated microglia [10, 44, 45], larvae are not trapped by inflamma-
tory reactions in cerebral tissues [44, 46]. Knowledge regarding the cerebral immune response
during NT is scarce. In the present study, an overall shift to an anti-inflammatory oxylipin
pattern during NT was found. In general, this trend was observed for T. canis- and T. cati-
infected mice, even though minor differences, especially for pro-inflammatory regulatory lip-
ids, between T. canis- and T. cati-induced NT were noted.
COX-derived prostaglandins are potent immunomodulatory mediators, triggering the
expression of inflammatory enzymes [47–50], chemokines and cytokines [51]. It is commonly
believed that ptgs1 (encoding for the enzyme COX-1) is expressed constitutively under
homeostatic conditions, whereas the expression of ptgs2 (encoding for the enzyme COX-2) is
induced in response to inflammatory stimuli [20]. However, recent data suggest that ptgs1 is a
major player in neuroinflammatory processes, while ptgs2 activity mediates neurotoxicity or
neuroprotection [52]. This hypothesis is supported by the transcriptomic analysis in the pres-
ent study, which revealed significantly increased levels of ptgs1-transcription in both brain
areas of T. canis-infected mice and at three time points in the cerebellum of T. cati-infected
mice, whereas ptgs2-transcription remained largely unaffected. Nevertheless, elevated tran-
scription rates of ptgs1 did not result in elevated concentrations of the corresponding oxyli-
pins, which were only moderately altered. Similar observations have been made regarding
cytokine secretion during NT. In a recent study, concentrations of pro-inflammatory
Fig 6. Transcriptional alterations (in fold-changes) of different ptgs- (encoding for COX enzymes) and alox- (encoding for LOX enzymes) genes
during T. canis- as well as T. cati-induced NT compared to uninfected mice. Data for day 42 pi have been deposited at the Gene Expression Omnibus
(GEO) database of the National Center for Biotechnology Information (NCBI) under the accession number GSE66094 [31].
https://doi.org/10.1371/journal.pntd.0007706.g006
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cytokines were also not elevated during T. canis- and T. cati-induced NT [40], although a tran-
scriptional upregulation of pro-inflammatory IFN-γ, IL-6 and TNF-α has been shown in
brains of T. canis-infected mice [46, 53].
Metabolites derived by the 5-LOX enzyme (encoded by alox5) are considered to have pro-
inflammatory properties. The transcription of alox5ap leading to FLAP, which is necessary to
initiate the activation of 5-LOX, was increased throughout the study period in cerebra and cer-
ebella of T. canis- as well as in cerebella of T. cati-infected animals. Alox5 transcription was
also elevated at these time points in T. canis-, but not in T. cati-infected animals. An important
5-LOX-derived regulatory lipid is LTB4, which activates and recruits neutrophils during
inflammatory processes [54, 55] and in interaction with pro-inflammatory cytokines, LTB4
induces the activation of NF-κB, a key regulator of neuroinflammation [56–58]. During the
course of T. canis- as well as T. cati-induced NT, LTB4 levels in the cerebellum were mainly
unaffected, while significantly increased levels were detected in the cerebrum during the sub-
acute phase and the beginning of the chronic phase of infection. Recruited neutrophils were,
besides eosinophils, shown to be present in perivascular lymphocytic cuffs of T. canis- and
T. cati-infected mice brains. However, neutrophil infiltration may play only a subordinate
role in the pathogenesis of NT as the pathological picture is dominated by eosinophilic menin-
gitis, microglia activation and neurodegeneration, the latter especially in T. canis-infected
mice [45].
The murine alox15 gene encodes for an enzyme that besides 15-lipoxygenation further acts
as a 12-lipoxygenating enzyme, converting PUFAs to products also formed by 12-LOX [13]
thus it is also referred to as 12/15-LOX. In the present study, alox12-transcription only showed
minor alterations in both infection groups, whereas alox15-transcription was significantly
upregulated at several time points pi. The highly increased levels of 12/15-LOX-metabolites at
days 14, 28 and 42 pi are thus most likely due to elevated alox15-transcription rates. Most 12/
15-LOX-metabolites exhibit anti-inflammatory properties. HETEs and HODEs are activators
of the peroxisomal proliferator-activating receptor-γ (PPARγ), which plays an important role
in the regulation of cell development and homeostasis [59]. Under neuroinflammatory condi-
tions, 12/15-LOX-metabolites mediate effects of anti-inflammatory IL-4 on NF-κB trans-acti-
vation in glial cells and protect oligodendrocyte progenitors [60]. In case of NT, these anti-
inflammatory and neuroprotective mechanisms may facilitate the persistence of Toxocara
spp.-larvae in the brain and the survival of the paratenic host.
Multiple enzymatic conversions of PUFAs result in formation of specialised pro-resolving
mediators (SPMs), including specific lipoxins, resolvins and protectins [51, 61, 62]. Besides
their anti-inflammatory properties, SPMs promote the resolution of inflammation by blocking
neutrophil recruitment and mediating phagocytosis and lymphatic clearance of apoptotic neu-
trophils [51]. Arachidonic acid-derived lipoxins, with LxA4 and LxB4 as the most prominent
metabolites, are involved in the regulation of leukocyte trafficking [61, 63, 64]. Interestingly,
even though LxA4 is involved in pro-resolving processes, LxA4 was not detected in any of the
study cohorts. In contrast, LxA4 seems to play an important role during cerebral toxoplasmo-
sis, with high levels of lipoxins suppressing the activation of dendritic cells and the secretion of
IL-12 [65]. Furthermore, anti-inflammatory and pro-resolving functions are also partially
mediated by resolvins, which can be separated in the EPA-derived E-series (RvEs) and the
DHA-derived D-series (RvDs) [66, 67]. In the present study, neither RvEs nor RvD1 were
present in detectable quantities in any of the study groups. However, the DHA-derived NPD1,
a major bioactive effector in both anti-inflammation and neuroprotection [68, 69] was success-
fully detected in the brains of the Toxocara-infected groups, but not in the uninfected control
group. In the T. canis- and T. cati-infected mice, NPD1 occurred primarily in the subacute
phase of infection between day 14 and 42 pi. In the brain, NPD1 has far-ranging properties
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regarding neural cell survival, protection of cerebral tissues and inhibition of leukocyte infiltra-
tion as well as interleukin 1-β-induced NF-κB activation [68, 70]. According to Ariel et al.
[71], NPD1 is produced by T-helper type 2-skewed peripheral blood mononuclear cells (Th2
PBMCs) in dependence of human ALOX-15 activity, but not in Th1 PBMCs. The “type 2”
polarisation of CD4+ T-helper cells, as part of the adaptive immune response, is commonly
induced by parasitic helminths [72, 73]. Del Prete et al. [74] demonstrated a stable Th2-like
cytokine secretion of human CD4+ T cells derived from the peripheral blood (PB), stimulated
with T. canis excretory/secretory (TES) antigen. Similarly to NPD1, 5,15-DiHETE and
8,15-DiHETE were detected in Toxocara-infected, but not in control mice. Both metabolites
are secreted in large quantities from eosinophils, and eosinophilic meningitis is one of the
most prominent pathologic features of NT in mice as well as in humans [6, 45].
The metabolites 9-HODE and 13-HODE as well as the ratio of both metabolites are pro-
posed biomarkers for various chronic diseases and the immunological status of an active infec-
tion [27, 28]. The low 13-/9-HODE ratio in the acute phase of influenza-infected C57BL/6
mice implied a pro-inflammatory state of the immune response, which was shifted to an anti-
inflammatory, pro-resolution state at later time points of the infection, indicated by a higher
13-/9-HODE ratio [28, 75]. This was also illustrated in the Lyme arthritis model of B. burgdor-
feri-infected C3H/HeJ and DBA/2J mice, with an elevated 13-/9-HODE ratio in the resistant
mouse strain (DBA), compared to the susceptible strain (C3H) [29, 75]. In the present study,
the 13-/9-HODE ratio in Toxocara-infected mice was clearly shifted towards an anti-inflam-
matory immune response in comparison to uninfected mice, particularly in the subacute
phase of infection between days 14 and 42 pi. Thus, the ratio of 13-/9-HODE reflects the afore-
mentioned trend of minor changes in the biosynthetic pathway of mostly pro-inflammatory
prostaglandins (COX-pathway) in concert with a significant increase of potentially anti-
inflammatory metabolites of the 12/15-LOX -pathway, observed for both infection groups and
brain regions.
In general, T. canis is regarded as the main causative agent of toxocarosis while the cat
roundworm T. cati is probably underestimated as a zoonotic pathogen [76]. In mice, T. cati-
induced NT is characterised by a less severe pathogenesis in terms of clinical symptoms, histo-
pathological alterations and behavioural changes compared to T. canis-infections [10, 11, 76].
Furthermore, T. canis-larvae exhibit higher neuroaffinity than T. cati-larvae and mainly accu-
mulate in the cerebrum, whereas T. cati prefers the cerebellum but mainly accumulates in
muscle tissue [10]. This species-specific tropism is partly reflected by alterations of the oxylipin
pattern, as significant elevations of pro-inflammatory COX- and 5-LOX-metabolites were
detected in the cerebellum rather than the cerebrum of T. cati-infected mice. Nevertheless, in
essence, alterations in the cerebral oxylipin patterns during T. canis- and T. cati-induced NT
were comparable. It remains unknown if the shift towards an anti-inflammatory oxylipin pat-
tern is an immunogenic reaction of the host in response to neuroinvasive larvae to prevent
excessive tissue damages or a parasite-induced immunomodulatory effect to evade the host’s
immune regulation, facilitating persistence in cerebral tissues. Many parasitic helminths are
known to manipulate the hosts’ immune response by secreting immunomodulatory compo-
nents evoking for example the induction of a modified Th2 response [77] and the reduction of
pro-inflammatory cytokines [78].
In conclusion, the present study revealed only minor changes in pro-inflammatory metabo-
lites of the COX-pathway in T. canis- and T. cati-infected cerebra and cerebella. Generally, it
should be kept in mind that NT is characterised by focally distributed lesions whereas entire
cerebra and cerebella were processed for the current analysis. Thus, healthy brain tissue
was overrepresented compared to damaged tissue, which may have masked local effects. Nev-
ertheless, a statistically significant increase of metabolites of different LOX-pathways was
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demonstrated for both infection groups. Neuroprotective NPD1 was detected in T. canis- and
T. cati-infected mice, especially in the subacute and at the beginning of the chronic phase of
infection, but not in uninfected mice. Other anti-inflammatory and pro-resolving SPMs were
not detected (LxA4, RvD1, RvEs). The ratio of 13-HODE to 9-HODE revealed a similar anti-
inflammatory immune response in the cerebrum and cerebellum of each infection group.
Even though T. canis infection resulted in more pronounced alterations in the pattern of lipid
mediators, T. canis- and T. cati-induced NT were comparable in terms of alterations of cere-
bral oxylipins over the course of infection.
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